INSIGHTS ON DRUG DEVELOPMENT
-
Navigating Nitrosamine Impurities In Pharmaceutical Drug Development
Understanding formation mechanisms and potency categorization allows developers to mitigate risks early, ensuring regulatory compliance and patient safety without compromising product performance.
-
3 Key Considerations In Gene Therapy Manufacturing
Viral vector-based gene therapies are redefining medicine. As developers navigate uncharted territory, Sybil Danby of Cytiva highlights three critical areas shaping the journey from discovery to patient access.
-
What To Consider When Looking For A CDMO In Drug Substance Utilization
Optimize drug substance use during fill/finish. Learn how advanced line configurations and 100% non-destructive weight checks mitigate process drift, protect therapeutics, and prevent product loss.
-
Identification Of GLP-1 Analog Oligomeric States Using SEC-MALS
Discover how SEC-MALS enables precise characterization of GLP-1a therapeutics to ensure formulation integrity and enhance safety, efficacy, and regulatory confidence.
-
Closing The QC Gap For mAbs: Rapid Answers Without Compromising6/9/2026
Monoclonal antibodies are complex biologics requiring precise analytical strategies to monitor critical quality attributes and impurities, with molecular assays like qPCR supporting sensitive detection, product integrity, and regulatory compliance.
-
Quicker Development Using Cell Line Integration, End-To-End Support6/19/2025
Despite challenges with mammalian host cell line diversity, Lonza's mitigation strategies drive efficiency and reproducibility, maximizing cell growth and product quality.
-
Reducing Cycle Time By 88% Through Strategic Solvent Replacement In Pharmaceutical Development10/14/2026
Replacing methylene chloride in a slow, labor-intensive API step led to a single-solvent, one-pot process with a shorter reaction time and improved yield and purity.
-
Tips And Tricks Addressing PCR Pain Points3/5/2026
qPCR workflows are vital but prone to common errors. Improve the precision and reliability of your gene expression data by mastering key strategies to overcome frequent experimental pitfalls.
-
Quantifying Endotoxins Via Absorbance Or Fluorescence3/20/2026
Find out how endotoxin assays use Factor C activation to generate measurable absorbance or fluorescence signals, with guidance on selecting detection formats and implementing scalable workflows.
DRUG DEVELOPMENT SOLUTIONS
-
Accelerate your gene therapy manufacturing with the Xcellerex™ X-platform – a next-generation single-use bioreactor system designed for viral vector workflows.
-
S APO Greenough Stereo Microscope
Save up to 20% inspection and rework time*
Continuously improving production, keeping defect rates low, and fulfilling customer requests in order to stay competitive can be very challenging. Leica has developed the S9 stereo microscope series to help you cope with these challenges. With this generation of Greenough stereo microscopes operators will be able to reveal details faster as they spend less time having to adjust the microscope.
*compared to the standard industrial stereo microscope S6 from Leica
-
Explore how key biomarkers like Amyloid-beta, TAU, and α-Synuclein are transforming neurodegeneration research, with enhanced detection strategies that improve diagnostic accuracy.
-
STELLARIS 5 Cryo Confocal Light Microscope
The STELLARIS 5 Cryo is a confocal light microscope system that helps you to target your area of interest for cryo-electron tomography (CryoET). The STELLARIS 5 Cryo gives you the precision to target reliably, while still offering superior performance you can count on and improved productivity for your experiments.
-
Our comprehensive network of manufacturing facilities enables us to offer robust supply assurance and consistent product quality to biopharmaceutical developers around the globe.